The QFix Encompass TM stereotactic radiosurgery (SRS) immobilization system consists of a thermoplastic mask that attaches to the couch insert to immobilize patients treated with intracranial SRS. This study evaluates the dosimetric impact and verifies a vendor provided treatment planning system (TPS) model in the Eclipse TPS. A thermoplastic mask was constructed for a Lucy 3D phantom, and was scanned with and without the Encompass TM system. Attenuation measurements were performed in the Lucy phantom with and without the insert using a pinpoint ion chamber for energies of 6xFFF, 10xFFF and 6X, with three field sizes (2 9 2, 4 9 4, and 6 9 6 cm 2 ). The measurements were compared to two sets of calculations. The first set utilized the vendor provided Encompass TPS model (Encompass TPS ), which consists of two structures: the Encompass and Encompass base structure. Three HU values for the Encompass (200, 300, 400) and Encompass Base (À600, À500, À400) structures were evaluated. The second set of calculations consists of the Encompass insert included in the external body contour (Encompass EXT ) for dose calculation. The average measured percent attenuation in the posterior region of the insert ranged from 3.4%-3.8% for the 6xFFF beam, 2.9%-3.4% for the 10xFFF, and 3.3%-3.6% for the 6X beam. The maximum attenuation occurred at the region where the mask attaches to the insert, where attenuation up to 17% was measured for a 6xFFF beam. The difference between measured and calculated attenuation with either the Encompass EXT or Encompass TPS approach was within 0.5%. HU values in the Encompass TPS model that provided the best agreement with measurement was 400 for the Encompass structure and À400 for the Encompass base structure. Significant attenuation was observed at the area where the mask attaches to the insert. Larger differences can be observed when using few static beams compared to rotational treatment techniques.
| INTRODUCTION

Intracranial stereotactic radiosurgery (SRS) is a treatment technique
used to deliver large doses of radiation to small targets in the cranium in order to manage primary brain tumors, metastasis, or functional diseases. Frameless mask-based systems have become popular over the past decade since they are noninvasive; allowing for greater patient comfort as well as the ability to fractionate treatments while still retaining the immobilization accuracy of frame-based treatments. [1] [2] [3] Current frameless-based systems typically use a clam shell style mask to immobilize the patient in order to provide submillimeter accuracy treatments to small intracranial lesions. 4 Frameless systems use either extensions in which the mask system extends off the patient support structure, or overlays in which the mask system is attached and indexed to the carbon fiber patient support structure. The QFix Encompass TM SRS immobilization system, created by QFix (Avondale, PA, USA) consists of a couch insert, and a thermoplastic mask attached to the raised component of the insert. The geometry and design of the insert is unique in that high density carbon fiber material surrounds the cranium, which may interfere with the target area to be treated.
Several groups have demonstrated the importance of modeling immobilization devices in the treatment planning system (TPS) to limit their dosimetric impact, particularly on skin dose, dose distribution, and attenuation. [5] [6] [7] [8] [9] [10] [11] A TPS model of the QFix Encompass insert has been created and is available in the Eclipse TPS software, v15. structures: Encompass and Encompass Base. The "Encompass" structure includes the bulk portion of the carbon fiber U-shaped insert.
| MATERIALS AND METHODS
The "Encompass Base" structure includes the posterior region of the insert system and is made up of a double-layered section with a hollow interior [ Fig. 1(b) ].
2.B | Phantom setup
Measurements were performed in a spherical, Lucy 3D QA phantom (Standard Imaging, Middleton WI, USA) with a PTW Pinpoint ion chamber (Freiburg, Germany), 0.015 cc active volume. The Lucy phantom was immobilized by creating a custom mask in the Encompass insert system [ Fig. 1(a) ]. A CT scan of the phantom and Encompass insert was acquired using the SRS protocol. The scan was imported into the TPS, where two image sets were generated based on how the Encompass system was to be included for dose calculation.
The first image set was the Encompass TPS image set (Encompass TPS ) which was contoured according to the vendor recommendations for incorporating the Encompass couch structure onto a patient image set. This consists of contouring the entire Encompass system in the external body contour, including the patient and mask.
The Encompass TPS model is inserted as a support structure, and then removed from the external body contour using the Boolean tool. The contouring procedure results in the external body contour encompassing the patient and mask, and the Encompass insert as a separate support structure [ Fig. 1(d) ]. This allows the dose calculation to take into account portions of the mask system that are custom to each patient and are not included in the couch structure.
The second image set was the Encompass external image set 
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Encompass insert to quantify the amount of attenuation, which was then compared with calculated values from the three image sets above.
2.C | Attenuation measurements
Measurements were performed on a Varian EDGE linear accelerator (Varian, Palo Alto, CA, USA) using three energies: a flattened 6 MV beam (6X), and flattening filter free 6 MV (6xFFF) and 10 MV (10xFFF) beams. The measurements were performed for each energy, with three field sizes: 2 9 2, 4 9 4, and 6 9 6 cm 2 . A total of 18 measurement setups were performed with and without the Encompass insert. The Encompass and Lucy setups were aligned using CBCT, matched to the TPS CT with 6 degrees of freedom.
A total of 41 measurements per energy and field size were performed. The measurements were broken down into four zones (Fig. 2 ).
Zone 1 (blue) is a 70°area that represents the area of the "Encompass 
2.D | Validation of HU Values for the Encompass
TPS Model
The HU values for the Encompass TPS model were determined for each of the structures in the Encompass model by choosing the HU that minimized the difference between the measured and calculated percent attenuation in a specific zone. The HU value for the "Encompass Base" structure was determined from measurements in Zone 1, the region of double-layered carbon fiber. The measurements were averaged and compared to the structure set HU values of À600, À500, and À400. Similarly, the HU value for the "Encompass" structure was determined by choosing the HU that minimized the difference between measured and calculated attenuation in Zone 3, the region that consists of only the carbon fiber insert. HU values of 200, 300, and 400 were evaluated in this study. To verify that all portions of the Encompass system were correctly modeled in the Encompass TPS model, the percent attenuation was also calculated with the Encompass TPS and compared to the percent attenuation calculated with the Encompass EXT image set.
2.E | Clinical case recalculation and measurement
Ten clinical cases were recalculated with the Encompass TPS model (Encompass TPS ) and compared to the clinical plan, where the Encompass system was taken into account in the external contour (Encompass EXT ). The targets in the ten clinical cases ranged in location as well as in size. The treatment techniques included volumetric modulated arc therapy (VMAT) and dynamic conformal arc (DCA); both techniques are implemented for SRS treatments at our institution. 
2.F | Couch placement sensitivity
The Encompass TPS model is manually registered and inserted on each patient image set. To evaluate the dosimetric uncertainty of the placement of the couch, the position of the couch model was intentionally displaced 3 mm in the vertical, lateral and longitudinal directions. This deviation was introduced to the Lucy phantom image set and the difference in dose to isocenter was evaluated between the intentional deviation and the baseline image set. The couch deviation was also applied to a patient image set, which showed the greatest discrepancy in dose calculation between the Encompass TPS and Encompass EXT images sets. For the patient data set, the dose to PTV D99% , PTV D95% , PTV D0.035 cc , OAR D0.035 cc , and point dose for each beam at isocenter were compared.
| RESULTS
3.A | Attenuation
In Zones 1-3, the average percent attenuation measured, Atten Measured, for the 6xFFF beam was 3.8%, 3.6%, and 3.4%, for the 10xFFF beam , and 6 9 6 cm 2 , respectively. The maximum difference between measured and calculated attenuation with the Encompass EXT was 3.6% which occurred in Zone4 for the 6xFFF beam for a 2 9 2 cm 2 field size.
3.B | HU validation
The HU values of the components of the Encompass systems are summarized in Table 3 . The final HU value chosen for the Encompass TPS was 400HU for the Encompass structure and À400 for the Encompass base structure. This minimized the difference between measured and calculated attenuation, (Atten Calc -Atten Measured ). The percent difference between the measured and calculated attenuation for the Encompass TPS for HU evaluation is summarized in Table 4 .
In Zones 1-3, the average difference between measured, Atten Measured, and calculated attenuation, Atten Calc, for the Encom- 
3.C | Clinical case recalculation and measurement
The average difference in PTV coverage between the patient data sets including the Encompass insert in the external with the TPS T A B L E 1 Summary of location, number of fractions, total dose, treatment technique and target volume for the 10 clinical cases in the study that were recalculated. Two plans treated two targets simultaneously, and the target volume for each target is shown. Percent difference in isocenter dose between measured and calculated with only Lucy (Lucy only ) and with Lucy in the Encompass system (Lucy ENC are summarized). Two lesions treated simultaneously with a single isocenter, dose measured at the center of larger of the two lesions.
Location Fractions
T A B L E 2 Summary of the percent attenuation measured using a pinpoint ion chamber for 6X, 6xFFF, and 10xFFF photon energies for field sizes of 2 9 2 cm 2 , 4 9 4 cm 2 , and 6 9 6 cm 2 . The magnitude of calculated attenuation between the Encompass EXT and Encompass TPS was similar. Differences in Zones 1 can be attributed to the way the Encompass base is modeled in the TPS model (Fig. 2) . The base layer of the Encompass insert consists of a double layer of high-density carbon fiber with a hollow center. The base layer was modeled as a solid piece due to the difficulty of modeling a thin layer of material in the TPS and transferring the T A B L E 3 Summary of components of the QFix Encompass TM SRS immobilization system, corresponding HU value ranges, and whether the component is included in the Encompass TPS model.
HU Range Included in TPS Model
Insert ( . HU values of 200, 300, 400 were evaluated for the frame structure and À600, À500, À400 for the base structure.
Encompass insert (HU)
Encompass base (HU) 6xFFF 200 300 400 À600 À500 À400 | 227 structure to subsequent patient image sets. Due to this, the Encompass base layer HU value is effectively an average of the Encompass insert (400) and air (À1000). Due to an increase in equivalent path length when traversing a larger portion of the high density insert at an oblique angle, compared to the perpendicular entry through the base structure, the differences are accentuated when the base is modeled with only one material. The HU value of À400 was chosen for the Encompass base structure in order to minimize the average difference in Zone 1, which more closely match the attenuation through the oblique angles. If the attenuation was matched more closely at Gantry 180, the difference in attenuation at the oblique angles would increase. Differences in Zone 4 can be attributed to the difficulty and inherent inaccuracy in measuring and calculating dose for small fields in areas of heterogeneity. 12,13 Zone 4 includes portions of the insert, mask, adjustable shims and acrylic pins. The maximum difference in measured and calculated attenuation was within 5%, which is within the uncertainty between measured and calculated dose found in previous studies. 9, 13, 14 It is important to include areas of high attenuation in the beam path to be included in the dose calculation. The TPS model is regis- however, this can change depending on where the location of the lesion is relative to the high density portions of the insert [ Fig. 3(a) ].
Depending on the couch angle, the change in isocenter dose varies between beams. During the SRS planning process, arc geometry is typically chosen to achieve conformal dose distributions rather than to avoid portions of the mask that are more attenuating. However, for static fields, such as IMRT or 3D conformal techniques, care
should be taken to avoid areas of high attenuation since the dosimetric consequences can be accentuated. Figure 3 (b) demonstrates an example of whole brain opposed lateral radiotherapy treatment for a patient initially simulated for an SRS treatment. Areas of high attenuation occur at the clip area, resulting in decreased coverage to the brain. The patient was ultimately treated with whole brain using a hippocampal sparing VMAT technique.
In this study, the anisotropic analytical algorithm (AAA) was used to verify the HU values of the TPS model. For AAA, inaccuracies in dose calculation have been demonstrated at the interfaces of materials. 13, 14 In the Encompass mask system, dose inaccuracies can occur between the mask, insert, and air. However beyond the interface region, dose from AAA is often comparable to Monte Carlo based algorithms, within 2%-4%. 15 Other studies have also found that couch models included in the external body contour for dose calculation often agree with measurements within 2%. 5, 9, 11 A limitation of this study is that skin dose was not evaluated.
Because the mask is an integral part of the Encompass system and is customized for each patient, the mask acts as additional build up and the amount may vary from patient to patient. Also, for rotational type techniques such as DCA or VMAT, dose to the skin is often spread out across the arc path length. Furthermore, the largest dosimetric differences occurred at gantry 270 through the shimming system of the mask. The change in attenuation when the shimming level is adjusted
was not evaluated, and may change as air gaps are introduced in the system. Future studies could be performed evaluating the dose to skin, as well as the impact of shimming level, static treatment fields as well as using more accurate algorithms such as Monte Carlo.
| CONCLUSION
Significant attenuation occurs when using the QFix Encompass TM SRS immobilization system, and occurs at the area where the mask attaches to the insert. HU values for the Encompass TPS model were found to be 400 for the Encompass structure and À400 for the Encompass base structure, which resulted in an average percent difference between measured and calculated attenuation of less than 0.5%. Small uncertainties in couch placement do not significantly perturb the dose calculation. However, larger differences can be seen when using few static beams compared to rotational treatment techniques. 
